Saved in:
Bibliographic Details
Main Authors: Zhang, Huiwen, Sun, Chen, Xia, Qing, Li, Peihai, Liu, Kechun, Zhang, Yun
Format: Artículo científico
Language:en
Published: Marine drugs 2024
Subjects:
Online Access:https://pubmed.ncbi.nlm.nih.gov/39452847/
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1868266287747039232
author Zhang, Huiwen
Sun, Chen
Xia, Qing
Li, Peihai
Liu, Kechun
Zhang, Yun
author_facet Zhang, Huiwen
Sun, Chen
Xia, Qing
Li, Peihai
Liu, Kechun
Zhang, Yun
Zhang, Huiwen
Sun, Chen
Xia, Qing
Li, Peihai
Liu, Kechun
Zhang, Yun
collection PubMed - marine biology
contents Brevianamide F Exerts Antithrombotic Effects by Modulating the MAPK Signaling Pathway and Coagulation Cascade. Zhang, Huiwen Sun, Chen Xia, Qing Li, Peihai Liu, Kechun Zhang, Yun Animals Zebrafish Molecular Docking Simulation Thrombosis Fibrinolytic Agents MAP Kinase Signaling System Blood Coagulation Disease Models, Animal Platelet Aggregation Existing antithrombotic drugs have side effects such as bleeding, and there is an urgent need to discover antithrombotic drugs with better efficacy and fewer side effects. In this study, a zebrafish thrombosis model was used to evaluate the antithrombotic activity and mechanism of Brevianamide F, a deep-sea natural product, with transcriptome sequencing analysis, RT-qPCR analysis, and molecular docking. The results revealed that Brevianamide F significantly attenuated the degree of platelet aggregation in the thrombus model zebrafish, leading to an increase in the number of circulating platelets, an augmentation in the return of blood to the heart, an elevated heart rate, and a significant restoration of caudal blood flow velocity. Transcriptome sequencing and RT-qPCR validation revealed that Brevianamide F may exert antithrombotic effects through the modulation of the MAPK signaling pathway and the coagulation cascade reaction. Molecular docking analysis further confirmed this result. This study provides a reference for the development of therapeutic drugs for thrombosis.
format Artículo científico
id pubmed_39452847
institution PubMed
language en
publishDate 2024
publisher Marine drugs
record_format pubmed
spellingShingle Brevianamide F Exerts Antithrombotic Effects by Modulating the MAPK Signaling Pathway and Coagulation Cascade.
Zhang, Huiwen
Sun, Chen
Xia, Qing
Li, Peihai
Liu, Kechun
Zhang, Yun
Animals
Zebrafish
Molecular Docking Simulation
Thrombosis
Fibrinolytic Agents
MAP Kinase Signaling System
Blood Coagulation
Disease Models, Animal
Platelet Aggregation
Brevianamide F Exerts Antithrombotic Effects by Modulating the MAPK Signaling Pathway and Coagulation Cascade. Zhang, Huiwen Sun, Chen Xia, Qing Li, Peihai Liu, Kechun Zhang, Yun Animals Zebrafish Molecular Docking Simulation Thrombosis Fibrinolytic Agents MAP Kinase Signaling System Blood Coagulation Disease Models, Animal Platelet Aggregation Existing antithrombotic drugs have side effects such as bleeding, and there is an urgent need to discover antithrombotic drugs with better efficacy and fewer side effects. In this study, a zebrafish thrombosis model was used to evaluate the antithrombotic activity and mechanism of Brevianamide F, a deep-sea natural product, with transcriptome sequencing analysis, RT-qPCR analysis, and molecular docking. The results revealed that Brevianamide F significantly attenuated the degree of platelet aggregation in the thrombus model zebrafish, leading to an increase in the number of circulating platelets, an augmentation in the return of blood to the heart, an elevated heart rate, and a significant restoration of caudal blood flow velocity. Transcriptome sequencing and RT-qPCR validation revealed that Brevianamide F may exert antithrombotic effects through the modulation of the MAPK signaling pathway and the coagulation cascade reaction. Molecular docking analysis further confirmed this result. This study provides a reference for the development of therapeutic drugs for thrombosis.
title Brevianamide F Exerts Antithrombotic Effects by Modulating the MAPK Signaling Pathway and Coagulation Cascade.
topic Animals
Zebrafish
Molecular Docking Simulation
Thrombosis
Fibrinolytic Agents
MAP Kinase Signaling System
Blood Coagulation
Disease Models, Animal
Platelet Aggregation
url https://pubmed.ncbi.nlm.nih.gov/39452847/